Urinary Tract Infections Caused by Extended-spectrum Beta-lactamase-producing Enterobacteria

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-10-24

Study Completion Date

2025-12-24

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Urinary tract infections (UTIs) are one of the most common pathologies encountered in general practice. However, with increasing bacterial resistance to antibiotics, their treatment is becoming increasingly complex. Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) pose a particular challenge due to their increased resistance to many commonly used antibiotics. The aim of this thesis is to study the management of such infections by general practitioners in Bas-Rhin and to suggest possible avenues for improvement.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Optimization Management Study of Community Urinary Tract Infections Spectrum

NCT03655548

Urinary Tract Infections Resistant Infection Community-Acquired Infections +1 more

COMPLETED

Impact of Beta-lactams on the Microbiota and Relative Fecal Abundance of Mulltidrug Resistant Bacteria

NCT03338738

Enterobacterial Infection

COMPLETED NA

Prognostic Factors of Escherichia Coli Bloodstream Infections: Severity Score and Therapeutic Implications

NCT02890901

Escherichia Coli Bloodstream Infection

COMPLETED

Understanding and Modeling Reservoirs, Vehicles and Transmission of ESBL-producing Enterobacteriaceae in the Community and Long Term Care Facilities

NCT03477084

Resistance Bacterial Enterobacteriaceae Infections

COMPLETED

Prevalence of Enterobacteria With Decreased Susceptibility to Carbapenems in Eastern Inter- Region

NCT02803710

Infection With Beta-lactam Resistance in Enterobacteriaceae

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Urinary Tract Infections

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult (≥18 years old)
* Subject with an Enterobacteriaceae urinary tract infection treated in a primary care setting for urinary tract infection between June 1, 2024 and December 31, 2024
* Subject not objecting, after being informed, to the reuse of their data for the purposes of this research.
* The subject's primary care physician agreeing to participate in the study

Exclusion Criteria

* Subject and/or their primary care physician having expressed their opposition to participating in the study
* Subject under legal protection
* Subject under guardianship or curatorship

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No